List Title | APhA DrugInfoLine

Psychiatry

SORT BY: Most Recent Most Viewed

December 11, 2018

Quetiapine prescribing decreased after clinicians received Medicare letters

READ

PREVIEW
High-volume primary care prescribers of quetiapine who received letters stating their use of the drug was higher than their peers and was under review by Medicare resulted in less prescribing of...
November 27, 2018

Medications used for substance abuse disorders may reduce suicidality, crime

READ

PREVIEW
Use of medications for alcohol or opioid abuse (e.g., naltrexone, buprenorphine, methadone) was associated with reductions in accidental overdoses, suicidal behaviors, and crime, according to...
September 25, 2018

Unsafe use of zolpidem is common

READ

PREVIEW
An assessment of national survey data from 2015 showed that many patients used zolpidem in unsafe ways, such as by administering higher-than-recommended doses (females and older adults), using the...
July 30, 2018

Depression may result from adverse medication effects

READ

PREVIEW
A U.S. population–based survey conducted over a 10-year period showed that a little more than one-third of patients used medications that list depression as a potential adverse effect, and the...
July 16, 2018

Pharmacogenetic-based decision tools are not interchangeable

READ

PREVIEW
A comparison of four commercially available pharmacogenetic-based decision tools in patients with major depressive disorder (MDD) and numerous treatment failures showed that genotype and predicted...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.